Welcome to the third episode of Care Partner's Compass: Navigating CRC on biomarkers.

I am joined again by CRC patient advocate and friend Annie Delores, whose information can be found here or through the podcast's website. 

In today's episode, we talk about the basics and importance of biomarkers and colorectal cancer.

Full transcription can be found on the website.

Host, producer/editor, and composer: Elsa Lankford
Guest: Annie Delores

And all the thanks and hugs in the world to Kristine. I can never tell you often enough how incredible you are. 

Please remember to share, subscribe, like, and rate the podcast.

Helpful links related to this episode:

• Biomarker page from Fight CRC
• Colorectal Cancer Alliance's biomarker info site
• Colontown University's "What are Biomarkers"

• (01:30) - Very basics of biomarkers
• (02:43) - HER2 (ERBB2) mutation
• (03:12) - Background on CRC
• (04:09) - Main CRC biomarkers
• (05:36) - Where to find the biomarkers
• (06:45) - MSI - Microsatellite Instability
• (08:09) - BRAF mutation
• (08:41) - First line clinical trials based on biomarkers
• (10:09) - KRAS and Stage 4
• (10:56) - Targeted treatments
• (12:17) - It can take time to understand biomarkers
• (14:05) - NGS (Next Generation Sequencing) reports
• (14:41) - Inherited mutations
• (15:12) - Biomarker testing as a standard